Patent · US Active

Inhibitors of integrin alpha 5 beta 1 and methods of use

US10836720B2 · kind B2 · utility

1Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 31, 2017
Grant dateNov 17, 2020
Priority date
Expiry dateMar 31, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D453/02
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed herein, inter alia, are inhibitors of integrin alpha 5 beta 1 and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.